“We are going to find out what’s causing autism and fund treatments that actually work.”
The promise
Kennedy pledged to lead a federal effort to study the biological causes of autism and expand clinical trials on leucovorin, a compound used to address folate receptor autoantibodies in some children. He claimed this could revolutionize treatment and diagnosis. Yet, no new large-scale trials were funded, and NIH pilot programs were quietly cancelled due to lack of evidence and ethical concerns. Medical experts criticized the initiative for diverting research money without results.
